These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 30627849)

  • 41. Prognostic and survival analysis of 837 Chinese colorectal cancer patients.
    Yuan Y; Li MD; Hu HG; Dong CX; Chen JQ; Li XF; Li JJ; Shen H
    World J Gastroenterol; 2013 May; 19(17):2650-9. PubMed ID: 23674872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.
    Rack B; Schindlbeck C; Jückstock J; Andergassen U; Hepp P; Zwingers T; Friedl TW; Lorenz R; Tesch H; Fasching PA; Fehm T; Schneeweiss A; Lichtenegger W; Beckmann MW; Friese K; Pantel K; Janni W;
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24832787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced prognostic value of combined circulating tumor cells and serum carcinoembryonic antigen in patients with colorectal cancer.
    Yang CY; Lin CC; Huang SC; Lu RH; Lo LC; Tseng JY; Tung CY; Lin CH; Jiang JK
    J Chin Med Assoc; 2023 May; 86(5):465-471. PubMed ID: 36821465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer.
    Ma S; Ling F; Gui A; Chen S; Sun Y; Li Z
    Med Sci Monit; 2017 Oct; 23():4808-4816. PubMed ID: 28986517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
    Wu P; Tang RN; Zou JH; Wang FC
    Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.
    Pierga JY; Hajage D; Bachelot T; Delaloge S; Brain E; Campone M; Diéras V; Rolland E; Mignot L; Mathiot C; Bidard FC
    Ann Oncol; 2012 Mar; 23(3):618-624. PubMed ID: 21642515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?
    Gazzaniga P; Raimondi C; Gradilone A; Biondi Zoccai G; Nicolazzo C; Gandini O; Longo F; Tomao S; Lo Russo G; Seminara P; Vincenzi B; Chimenti I; Cristofanilli M; Frati L; Cortesi E
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1411-6. PubMed ID: 23736274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
    Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer.
    Shen F; Zhu Y; Wang F; Cai X; Ding H; Zhou F; Wang J; Gu H; Liu C; Li Q
    Colorectal Dis; 2022 Jan; 24(1):68-76. PubMed ID: 34611964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of a semi-automated NanoVelcro system in capturing circulating tumor cells and evaluating their prognostic value for gestational choriocarcinoma.
    Hou M; Zheng Y; Ding Z; He S; Xu M; Chen X; Zhang H; Zeng C; Sun C; Jiang W; Wang H; Shen H; Zhang Y; Liu J; Sun S; Jiang N; Cui Y; Sun Y; Chen Y; Cao J; Wang C; Li M; Zhang Y; Wang J; Lin M; Ke Z
    Biomater Sci; 2019 Feb; 7(3):1200-1210. PubMed ID: 30656300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
    Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
    Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients.
    Kohli M; Li J; Du M; Hillman DW; Dehm SM; Tan W; Carlson R; Campion MB; Wang L; Wang L; Zhang H; Zhang P; Kilari D; Huang CC; Wang L
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):411-418. PubMed ID: 29858592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.
    Messaritakis I; Sfakianaki M; Papadaki C; Koulouridi A; Vardakis N; Koinis F; Hatzidaki D; Georgoulia N; Kladi A; Kotsakis A; Souglakos J; Georgoulias V
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):767-775. PubMed ID: 30094617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.
    Liu Z; Gu Y; Yu F; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Qian W; Li X
    Evid Based Complement Alternat Med; 2022; 2022():4162354. PubMed ID: 36193123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer.
    Chou WC; Wu MH; Chang PH; Hsu HC; Chang GJ; Huang WK; Wu CE; Hsieh JC
    Int J Biol Sci; 2018; 14(2):137-146. PubMed ID: 29483832
    [No Abstract]   [Full Text] [Related]  

  • 59. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
    Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
    Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.